Immunotherapy in Patients With Metastatic Cancers and CDK12 Mutations

Clinical trial NCT03570619 · COMPLETED

Trial details

NCT number: NCT03570619
Sponsor: University of Michigan Rogel Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Castration Resistant Prostate Cancer Metastatic Cancer Solid Tumor

Start date: 2018-12-14
Primary completion: 2022-12-22
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.